9 | Proteins (Proteins, Gene)FDA Link
01/2016
-
11/2007 |
6 | Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
06/2021
-
12/2004 |
5 | N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA
12/2022
-
05/2008 |
4 | Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA
12/2022
-
05/2006 |
4 | LigandsIBA
12/2022
-
12/2008 |
4 | Oxidopamine (6 Hydroxydopamine)IBA
06/2021
-
07/2012 |
4 | Quinolinic AcidIBA
01/2021
-
01/2013 |
4 | Amyloid (Amyloid Fibrils)IBA
01/2021
-
12/2010 |
3 | Cholinergic Agents (Cholinergics)IBA
12/2022
-
05/2006 |
3 | N- (1- azabicyclo(2.2.2)oct- 3- yl)furo(2,3- c)pyridine- 5- carboxamideIBA
06/2021
-
01/2015 |
3 | Neuroprotective AgentsIBA
06/2021
-
09/2012 |
3 | Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2019
-
05/2003 |
3 | PK 11195 (PK11195)IBA
01/2016
-
12/2010 |
3 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
07/2013
-
12/2003 |
2 | MelatoninIBA
11/2021
-
10/2016 |
2 | pyridineIBA
06/2021
-
02/2008 |
2 | Neuropeptide YIBA
10/2019
-
09/2012 |
2 | 8- ((E)- 4- fluoro- but- 2- enyl)- 3beta- p- tolyl- 8- aza- bicyclo(3.2.1)octane- 2beta- carboxylic acid methyl esterIBA
01/2019
-
01/2015 |
2 | Purinergic P2X7 ReceptorsIBA
01/2018
-
01/2018 |
2 | LipopolysaccharidesIBA
10/2016
-
10/2008 |
2 | CytokinesIBA
01/2016
-
05/2012 |
2 | Levodopa (L Dopa)FDA LinkGeneric
07/2013
-
01/2004 |
2 | Peptides (Polypeptides)IBA
03/2012
-
01/2004 |
2 | Valproic Acid (Depakote)FDA LinkGeneric
04/2011
-
02/2010 |
2 | 2,3-dihydro-1H-imidazo(1,2-b)pyrazole (IMPY)IBA
12/2010
-
02/2008 |
2 | PrionsIBA
12/2010
-
02/2008 |
2 | Dopamine (Intropin)FDA LinkGeneric
01/2008
-
01/2004 |
2 | Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
03/2006
-
01/2003 |
2 | N- (3- iodoprop- 2- enyl)- 2- beta- carbomethoxy- 3- (4- methylphenyl)nortropaneIBA
07/2003
-
05/2003 |
1 | fluoroethoxy-benzovesamicolIBA
12/2022 |
1 | P-SelectinIBA
12/2022 |
1 | Sigma-1 ReceptorIBA
06/2021 |
1 | Cholinergic ReceptorsIBA
01/2021 |
1 | 4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA
01/2021 |
1 | ResveratrolIBA
01/2021 |
1 | EnzymesIBA
01/2021 |
1 | ImmunosorbentsIBA
01/2021 |
1 | Glutamic Acid (Glutamate)FDA Link
01/2021 |
1 | A-factor (Streptomyces)IBA
10/2020 |
1 | Acetylcholine (Acetylcholine Chloride)FDA Link
01/2020 |
1 | EstersIBA
12/2019 |
1 | BoronIBA
12/2019 |
1 | Cocaine (Cocaine HCl)IBA
01/2019 |
1 | Heme Oxygenase-1IBA
01/2018 |
1 | Adenosine Triphosphate (ATP)IBA
01/2018 |
1 | Antidepressive Agents (Antidepressants)IBA
01/2018 |
1 | ElementsIBA
01/2018 |
1 | Sirtuin 1IBA
10/2016 |
1 | Leucine-Rich Repeat Serine-Threonine Protein Kinase-2IBA
01/2016 |
1 | SynucleinsIBA
01/2016 |
1 | NicotineFDA Link
01/2015 |
1 | Methylphenidate (Ritalin)FDA LinkGeneric
10/2014 |
1 | Reactive Oxygen Species (Oxygen Radicals)IBA
01/2013 |
1 | Heme (Haem)IBA
01/2013 |
1 | IronIBA
01/2013 |
1 | Interleukin-6 (Interleukin 6)IBA
05/2012 |
1 | InterleukinsIBA
03/2012 |
1 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2012 |
1 | Ethanol (Ethyl Alcohol)IBA
04/2011 |
1 | TeratogensIBA
04/2011 |
1 | Thalidomide (Thalomid)FDA Link
04/2011 |
1 | Misoprostol (Cytotec)FDA LinkGeneric
04/2011 |
1 | Glycoproteins (Glycoprotein)IBA
12/2010 |
1 | Essential Fatty AcidsIBA
12/2009 |
1 | Fatty Acids (Saturated Fatty Acids)IBA
12/2009 |